CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,228,500 | +164.4% | 50,000 | +66.7% | 0.05% | +165.0% |
Q3 2022 | $843,000 | +76.0% | 29,993 | +68.7% | 0.02% | +53.8% |
Q2 2022 | $479,000 | -21.0% | 17,781 | 0.0% | 0.01% | -13.3% |
Q1 2022 | $606,000 | -63.6% | 17,781 | -81.3% | 0.02% | -16.7% |
Q4 2020 | $1,664,000 | – | 95,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |